Dr. Marcel Behr is a clinician-scientist. He was the founding Director of the McGill International TB Centre and led it from 2012 to 2018. He is Director of the McGill Infectious Diseases Division and the McGill Interdisciplinary Initiative in Infection and Immunity (MI4).
Dr. Behr trained at the University of Toronto, Queen’s, McGill and Stanford. His work has clarified the natural history of TB, determined the basis of Bacillus Calmette-Guérin (BCG) attenuation, identified differences between related mycobacterial species, and explained the molecular basis for the use of mycobacteria as immune adjuvants.
Current Research Projects:
- Tuberculosis preventive treatments (TPT) model with Dr. Andréanne Lupien and Dr. Richard Menzies.
- Immunization against zoonotic TB strains with Dr. Maziar Divangahi.
- Single-cell sequence analysis of zoonotic TB strains with Dr. Erwin Schurr.
- Working with Dr. Luke Harrison on Mycobacterium tuberculosis evolution.
Email: marcel.behr [at] mcgill.ca
